These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12469148)

  • 1. Prognostic factors in patients with squamous oesophageal cancer associated with solitary lymph node metastasis after oesophagectomy and extended lymphadenectomy.
    Takemura M; Osugi H; Takada N; Kinoshita H; Higashino M
    Oncol Rep; 2003; 10(1):75-80. PubMed ID: 12469148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors after oesophagectomy and extended lymphadenectomy for squamous oesophageal cancer.
    Osugi H; Takemura M; Takada N; Hirohashi K; Kinoshita H; Higashino M
    Br J Surg; 2002 Jul; 89(7):909-13. PubMed ID: 12081742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy.
    Nakagawa S; Kanda T; Kosugi S; Ohashi M; Suzuki T; Hatakeyama K
    J Am Coll Surg; 2004 Feb; 198(2):205-11. PubMed ID: 14759776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
    Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N
    Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of death and pattern of recurrence after esophagectomy and extended lymphadenectomy for squamous cell carcinoma of the thoracic esophagus.
    Osugi H; Takemura M; Higashino M; Takada N; Lee S; Ueno M; Tanaka Y; Fukuhara K; Hashimoto Y; Fujiwara Y; Kinoshita H
    Oncol Rep; 2003; 10(1):81-7. PubMed ID: 12469149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of lymph node status in superficial esophageal carcinoma.
    Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
    Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
    Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
    Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma.
    Sato F; Shimada Y; Li Z; Watanabe G; Maeda M; Imamura M
    Br J Surg; 2001 Mar; 88(3):426-32. PubMed ID: 11260111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent esophageal carcinoma after esophagectomy with three-field lymph node dissection.
    Kato H; Tachimori Y; Watanabe H; Igaki H; Nakanishi Y; Ochiai A
    J Surg Oncol; 1996 Apr; 61(4):267-72. PubMed ID: 8627996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
    Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
    Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative pathological investigation of recurrent nerve nodal metastasis can guide the decision whether to perform cervical lymph node dissection in thoracic esophageal cancer.
    Ueda Y; Shiozaki A; Itoi H; Okamoto K; Fujiwara H; Ichikawa D; Kikuchi S; Fuji N; Itoh T; Ochiai T; Komatsu S; Yamagishi H
    Oncol Rep; 2006 Nov; 16(5):1061-6. PubMed ID: 17016593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and clinical evaluation of salvage operation for cervical lymph node recurrence in esophageal cancer.
    Komatsu S; Shioaki Y; Ichikawa D; Hamashima T; Kan K; Ueshima Y; Koide K; Lee CJ; Ikeda E; Mutoh F; Kurioka H; Oka T; Yamagishi H
    Hepatogastroenterology; 2005; 52(63):796-9. PubMed ID: 15966207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
    Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
    Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].
    Chen G; Wang Z; Liu XY; Liu FY
    Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulations and lymphadenectomy strategy of mediastinal and upper abdominal lymph node metastasis in thoracic esophageal carcinoma].
    Xue HC; Wu CR; Zhang ZB; Zhu ZH; Ma ZK; Gao J
    Ai Zheng; 2007 Sep; 26(9):1020-4. PubMed ID: 17927865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma.
    Chen J; Liu S; Pan J; Zheng X; Zhu K; Zhu J; Xiao J; Ying M
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):480-6. PubMed ID: 19502077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
    Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
    J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recurrence pattern and prognosis of esophageal cancer following tumor resection].
    Chen J; Sang M; Chen Y
    Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):293-5. PubMed ID: 10920988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of immunohistochemical nodal micrometastasis as a prognostic indicator in potentially curable oesophageal carcinoma.
    Komukai S; Nishimaki T; Suzuki T; Kanda T; Kuwabara S; Hatakeyama K
    Br J Surg; 2002 Feb; 89(2):213-9. PubMed ID: 11856137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.